Results 41 to 50 of about 1,792,800 (248)
Design and analysis strategies for robust microbiome ageing research
The gut microbiome changes with age and associates with age‐related morbidity and mortality, establishing it as a potential biomarker and intervention target for ageing. Realising this potential requires methodological rigour, yet distinguishing biological signals from methodological artefacts remains challenging across cohorts. This review provides an
Mark Olenik +5 more
wiley +1 more source
Background Growing availability of laboratory test result information in large healthcare databases presents opportunities to improve confounding control. Whilst information on the ordering of tests and the resulting continuous test values are available,
John Tazare +6 more
doaj +1 more source
Distribution of estimated propensity scores and region of common support.
Distribution of estimated propensity scores and region of common support.
Pallavi Rajkhowa (11619488) +1 more
core +1 more source
Engineering peptides into antibodies—opportunities and strategies for therapeutic innovation
Peptides and antibodies occupy complementary therapeutic niches. Peptides recognize difficult targets in a compact format, while antibodies add specificity, long half‐life, and effector functions. This review examines strategies that merge both modalities—peptide grafting into loops, terminal and Fc fusions, and bioconjugation—highlighting how ...
Jinling Wang +2 more
wiley +1 more source
BackgroundEarly adulthood is a turning-point for educational attainment and family formation. Our understanding of whether family formation predicts educational attainment is incomplete for two growing populations: unmarried families and community ...
Janet E. Rosenbaum
doaj +1 more source
Background Short-acting β2-agonist (SABA) nebulization is commonly prescribed for children hospitalized with severe asthma exacerbation. Either intermittent or continuous delivery has been considered safe and efficient.
Prapasri Kulalert +5 more
doaj +1 more source
Obesity raises blood levels of PAI‐1, a protein linked to metabolic dysfunction‐associated steatotic liver disease in people with obesity. In female mice fed a high‐fat diet, partially lowering PAI‐1 led to smaller subcutaneous fat cells and lower liver cholesterol, without changing body weight or insulin sensitivity.
Claudia E. Ramirez Bustamante +10 more
wiley +1 more source
IntroductionMachine learning (ML) methods are promising and scalable alternatives for propensity score (PS) estimation, but their comparative performance in disease risk score (DRS) estimation remains unexplored.MethodsWe used real-world data comparing ...
Yuchen Guo +6 more
doaj +1 more source
Pathway to Ascertain the Role of Pharmacogenomics in Healthcare Utilization Outcomes [Letter]
Youssef M Roman Department of Pharmacotherapy and Outcomes Science, Virginia Commonwealth University School of Pharmacy, Richmond, VA, 23298, USACorrespondence: Youssef M RomanDepartment of Pharmacotherapy and Outcomes Science, Virginia Commonwealth ...
Roman YM
doaj

